Changes

Jump to: navigation, search

Combining-Valproic acid-Gabapentin

668 bytes added, 00:51, 10 March 2010
Created page with '{{Drugcombi | base = valproic acid | add = gabapentin | info = * Valproic acid is principally metabolized by CYP2C9, CYP2C19, CYP2A6 and UDP-glucuronosyltransferases. Valproic a...'
{{Drugcombi
| base = valproic acid
| add = gabapentin
| info =
* Valproic acid is principally metabolized by CYP2C9, CYP2C19, CYP2A6 and UDP-glucuronosyltransferases. Valproic acid is an inhibitor of the enzymes CYP2C9, epoxide-hydroxylase and UDP-glucuronosyltransferases.
* Gabapentine is eliminated unchanged by the kidney for 100%. Changes in the rate of excretion can cause unwanted effects.
* This combination of drugs may have possible synergistic effects. There are no reports for pharmacokinetic drug interactions. However, the combination will have additional side effects.
| start =
* Start gabapentin according to the general dosing advice.
| cave =
}}
387
edits

Navigation menu